Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acyl-CoA wax alcohol acyltransferase 2 (AWAT2) is an enzyme that catalyzes the esterification of long-chain fatty alcohols with acyl-CoA-derived fatty acids to generate wax esters—neutral lipids critical for the functional lipid composition of skin (sebum), meibum (from meibomian glands), and certain ocular tissues[3][5]. AWAT2 also has acyl-CoA:retinol acyltransferase (ARAT) activity, specifically supporting the formation of 11-cis-retinyl esters in the retina, which are essential for the regeneration of cone visual pigment and maintenance of daylight/color vision[1]. The enzyme is highly expressed in skin appendages such as sebaceous and meibomian glands and is crucial for normal lipid production and eye surface homeostasis. Genetic AWAT2 deficiency causes blockage of meibomian glands and evaporative dry eye in animal models[4][5]. AWAT2 is part of the diacylglycerol acyltransferase family and displays substrate specificity regulated at least in part by allosteric effects of its lipid ligands[1][3][5].
Not applicable; as of 2024, no drugs are known to target AWAT2 directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acyl-CoA wax alcohol acyltransferase 2 (AWAT2).